{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:30:33Z","timestamp":1790544633351,"version":"4.1.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100021772","name":"Deanship of Scientific Research, University of Jordan","doi-asserted-by":"publisher","award":["DSR2022-RG-0147"],"award-info":[{"award-number":["DSR2022-RG-0147"]}],"id":[{"id":"10.13039\/501100021772","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007614","name":"Jouf University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007614","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.bioorg.2023.106404","type":"journal-article","created":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T21:01:06Z","timestamp":1676322066000},"page":"106404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Phthalazone tethered 1,2,3-triazole conjugates: In silico molecular docking studies, synthesis, in vitro antiproliferative, and kinase inhibitory activities"],"prefix":"10.1016","volume":"133","author":[{"given":"Mohamed A","family":"Abdelgawad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Nasir Abbas","family":"Bukhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arafa","family":"Musa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Elmowafy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AbdElAziz A.","family":"Nayl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed H.","family":"El\u2010Ghorab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Sadek Abdel-Bakky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hany A.","family":"Omar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasser","family":"Hadal Alotaibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossam M.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed M.","family":"Ghoneim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rania B.","family":"Bakr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2023.106404_b0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: Cancer J Clin"},{"key":"10.1016\/j.bioorg.2023.106404_b0010","doi-asserted-by":"crossref","first-page":"M915","DOI":"10.3390\/M915","article-title":"(3, 5-Dimethylpyrazol-1-yl)-[4-(1-phenyl-1H-pyrazolo [3, 4-d] pyrimidin-4-ylamino) phenyl] methanone","volume":"2016","author":"Bakr","year":"2016","journal-title":"Molbank"},{"key":"10.1016\/j.bioorg.2023.106404_b0015","doi-asserted-by":"crossref","unstructured":"R. B Bakr, A. BM Mehany, K. RA Abdellatif. Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3, 6-dimethyl-1-phenyl-4-(substituted-methoxy) pyrazolo [3, 4-d] pyrimidine Derivatives. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents) 17, 1389-1400 (2017).","DOI":"10.2174\/1872211311666170213105004"},{"key":"10.1016\/j.bioorg.2023.106404_b0020","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1148\/rg.2019180061","article-title":"Recognizing radiation therapy\u2013related complications in the chest","volume":"39","author":"Benveniste","year":"2019","journal-title":"Radiographics"},{"key":"10.1016\/j.bioorg.2023.106404_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2021.106983","article-title":"Review of the risk of cancer following low and moderate doses of sparsely ionising radiation received in early life in groups with individually estimated doses","volume":"159","author":"Little","year":"2022","journal-title":"Environ Int"},{"key":"10.1016\/j.bioorg.2023.106404_b0030","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3389\/fphar.2018.00245","article-title":"Adverse effects of cancer chemotherapy: Anything new to improve tolerance and reduce sequelae?","volume":"9","author":"Nurgali","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bioorg.2023.106404_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40169-018-0185-6","article-title":"Analyses of repeated failures in cancer therapy for solid tumors: Poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs","volume":"7","author":"Maeda","year":"2018","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.bioorg.2023.106404_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2019.100646","article-title":"The emergence of drug resistance to targeted cancer therapies: Clinical evidence","volume":"47","author":"Sarmento-Ribeiro","year":"2019","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.bioorg.2023.106404_b0045","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.ejim.2009.07.009","article-title":"The role of angiogenesis in solid tumours: an overview","volume":"20","author":"Makrilia","year":"2009","journal-title":"European journal of internal medicine"},{"key":"10.1016\/j.bioorg.2023.106404_b0050","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.critrevonc.2007.01.006","article-title":"Vascular endothelial growth factor (VEGF) signaling in tumor progression","volume":"62","author":"Roskoski","year":"2007","journal-title":"Critical reviews in oncology\/hematology"},{"key":"10.1016\/j.bioorg.2023.106404_b0055","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1152\/physrev.00038.2010","article-title":"Normalization of the vasculature for treatment of cancer and other diseases","volume":"91","author":"Goel","year":"2011","journal-title":"Physiological reviews"},{"key":"10.1016\/j.bioorg.2023.106404_b0060","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrm.2016.87","article-title":"Mechanisms and regulation of endothelial VEGF receptor signalling","volume":"17","author":"Simons","year":"2016","journal-title":"Nature reviews Molecular cell biology"},{"key":"10.1016\/j.bioorg.2023.106404_b0065","doi-asserted-by":"crossref","DOI":"10.1088\/2057-1739\/aa9263","article-title":"Matrix stiffness enhances VEGFR-2 internalization, signaling, and proliferation in endothelial cells","volume":"3","author":"LaValley","year":"2017","journal-title":"Convergent Science Physical Oncology"},{"key":"10.1016\/j.bioorg.2023.106404_b0070","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/14756366.2021.2007905","article-title":"Topo II inhibition and DNA intercalation by new phthalazine-based derivatives as potent anticancer agents: design, synthesis, anti-proliferative, docking, and in vivo studies","volume":"37","author":"Khalifa","year":"2022","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bioorg.2023.106404_b0075","article-title":"Controlled microwave-assisted reactions: A facile synthesis of polyfunctionally substituted phthalazines as dual EGFR and PI3K inhibitors in CNS SNB-75 cell line","volume":"105740","author":"Nazmy","year":"2022","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bioorg.2023.106404_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112412","article-title":"Inhibitor design to target a unique feature in the folate pocket of Staphylococcus aureus dihydrofolate reductase","volume":"200","author":"Muddala","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bioorg.2023.106404_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103004","article-title":"Synthesis, biological evaluation and in silico studies of novel N-substituted phthalazine sulfonamide compounds as potent carbonic anhydrase and acetylcholinesterase inhibitors","volume":"89","author":"T\u00fcrke\u015f","year":"2019","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bioorg.2023.106404_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103647","article-title":"Cholinesterases, \u03b1-glycosidase, and carbonic anhydrase inhibition properties of 1H-pyrazolo[1,2-b] phthalazine-5,10-dione derivatives: Synthetic analogues for the treatment of Alzheimer's disease and diabetes mellitus","volume":"97","author":"Taslimi","year":"2020","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bioorg.2023.106404_b0095","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ejmech.2017.07.072","article-title":"New racemic annulated pyrazolo[1, 2-b]phthalazines as tacrine-like AChE inhibitors with potential use in Alzheimer's disease","volume":"139","author":"Jalili-Baleh","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bioorg.2023.106404_b0100","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3109\/14756366.2013.782300","article-title":"Synthesis and blood glucose lowering activity of some novel benzenesulfonylthiourea derivatives substituted with 4-aryl-1-oxophthalazin-2 (1H) yl-ones","volume":"29","author":"Yaseen","year":"2014","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bioorg.2023.106404_b0105","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11030-018-9871-y","article-title":"Phthalazine-1,4-dione derivatives as non-competitive AMPA receptor antagonists: Design, synthesis, anticonvulsant evaluation, ADMET profile and molecular docking","volume":"23","author":"El-Helby","year":"2019","journal-title":"Mol Divers"},{"key":"10.1016\/j.bioorg.2023.106404_b0110","doi-asserted-by":"crossref","first-page":"1800387","DOI":"10.1002\/ardp.201800387","article-title":"Design, synthesis, in silico ADMET profile and GABA-A docking of novel phthalazines as potent anticonvulsants","volume":"352","author":"El-Helby","year":"2019","journal-title":"Arch Pharm"},{"key":"10.1016\/j.bioorg.2023.106404_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116161","article-title":"Rational modification, synthesis and biological evaluation of N-substituted phthalazinone derivatives designed to target interleukine-15 protein","volume":"39","author":"Smadja","year":"2021","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bioorg.2023.106404_b0120","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.bmcl.2016.02.008","article-title":"Synthesis and anti-inflammatory activity evaluation of a novel series of 6-phenoxy-[1,2,4]triazolo[3, 4-a]phthalazine-3-carboxamide derivatives","volume":"26","author":"Liu","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bioorg.2023.106404_b0125","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1021\/acs.jmedchem.5b00183","article-title":"Discovery of N-(4-(3-(2-aminopyrimidin-4-yl)pyridin-2-yloxy)phenyl)-4-(4-methylthiophen-2-yl)phthalazin-1-amine (AMG 900), a highly selective, orally bioavailable inhibitor of aurora kinases with activity against multidrug-resistant cancer cell lines","volume":"58","author":"Geuns-Meyer","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.bioorg.2023.106404_b0130","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.bioorg.2019.03.068","article-title":"Design and synthesis of novel PARP-1 inhibitors based on pyridopyridazinone scaffold","volume":"87","author":"Elmasry","year":"2019","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bioorg.2023.106404_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103181","article-title":"Design, synthesis and evaluation of phthalazinone thiohydantoin-based derivative as potent PARP-1 inhibitors","volume":"91","author":"Zhong","year":"2019","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bioorg.2023.106404_b0140","doi-asserted-by":"crossref","first-page":"2000456","DOI":"10.1002\/ardp.202000456","article-title":"Discovery of novel triazolophthalazine derivatives as DNA intercalators and topoisomerase II inhibitors","volume":"354","author":"Sakr","year":"2021","journal-title":"Arch Pharm"},{"key":"10.1016\/j.bioorg.2023.106404_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104233","article-title":"Design, synthesis, molecular modeling, in vivo studies and anticancer activity evaluation of new phthalazine derivatives as potential DNA intercalators and topoisomerase II inhibitors","volume":"103","author":"El-Helby","year":"2020","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bioorg.2023.106404_b0150","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ejmech.2016.02.029","article-title":"Increasing the binding affinity of VEGFR-2 inhibitors by extending their hydrophobic interaction with the active site: Design, synthesis and biological evaluation of 1-substituted-4-(4-methoxybenzyl) phthalazine derivatives","volume":"113","author":"Eldehna","year":"2016","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/j.bioorg.2023.106404_b0155","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ejmech.2015.10.053","article-title":"1-Piperazinylphthalazines as potential VEGFR-2 inhibitors and anticancer agents: synthesis and in vitro biological evaluation","volume":"107","author":"Abou-Seri","year":"2016","journal-title":"European journal of medicinal chemistry"},{"key":"10.1016\/j.bioorg.2023.106404_b0160","doi-asserted-by":"crossref","first-page":"1700240","DOI":"10.1002\/ardp.201700240","article-title":"Design, synthesis, molecular docking, and anticancer activity of phthalazine derivatives as VEGFR-2 inhibitors","volume":"350","author":"El-Helby","year":"2017","journal-title":"Archiv der Pharmazie"},{"key":"10.1016\/j.bioorg.2023.106404_b0165","doi-asserted-by":"crossref","first-page":"2100201","DOI":"10.1002\/ardp.202100201","article-title":"Phthalazine-based VEGFR-2 inhibitors: Rationale, design, synthesis, in silico, ADMET profile, docking, and anticancer evaluations","volume":"354","author":"Khedr","year":"2021","journal-title":"Archiv der Pharmazie"},{"key":"10.1016\/j.bioorg.2023.106404_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.131855","article-title":"Synthesis, in vitro antimicrobial evaluation, and molecular docking studies of new isatin-1, 2, 3-triazole hybrids","volume":"1250","author":"El Malah","year":"2022","journal-title":"J Mol Struct"},{"key":"10.1016\/j.bioorg.2023.106404_b0175","doi-asserted-by":"crossref","first-page":"10822","DOI":"10.1039\/D1NJ00773D","article-title":"Synthesis and antibiofilm activity of 1,2,3-triazole-pyridine hybrids against methicillin-resistant Staphylococcus aureus (MRSA)","volume":"45","author":"El Malah","year":"2021","journal-title":"New J Chem"},{"key":"10.1016\/j.bioorg.2023.106404_b0180","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3390\/molecules25040790","article-title":"Design, synthesis, and antimicrobial activities of 1,2,3-triazole glycoside clickamers","volume":"25","author":"El Malah","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2023.106404_b0185","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3389\/fcimb.2017.00304","article-title":"Identification of novel and efficacious chemical compounds that disturb influenza A virus entry in vitro","volume":"7","author":"Khalil","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.bioorg.2023.106404_b0190","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1039\/C4MD00039K","article-title":"Synthesis and antiviral evaluation of 4\u2032-(1,2,3-triazol-1-yl)thymidines","volume":"5","author":"Vernekar","year":"2014","journal-title":"Medchemcomm"},{"key":"10.1016\/j.bioorg.2023.106404_b0195","article-title":"Design, synthesis, biological investigations and molecular interactions of triazole linked tacrine glycoconjugates as Acetylcholinesterase inhibitors with reduced hepatotoxicity","volume":"118","author":"Gulati","year":"2022","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bioorg.2023.106404_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.132229","article-title":"Synthesis, and in vitro biological evaluations of novel naphthoquinone conjugated to aryl triazole acetamide derivatives as potential anti-Alzheimer agents","volume":"1255","author":"Hosseini","year":"2022","journal-title":"J Mol Struct"},{"key":"10.1016\/j.bioorg.2023.106404_b0205","article-title":"A review on synthesis, mechanism of action, and structure-activity relationships of 1,2,3-triazole-based \u03b1-glucosidase inhibitors as promising anti-diabetic agents","volume":"132469","author":"Fallah","year":"2022","journal-title":"J Mol Struct"},{"key":"10.1016\/j.bioorg.2023.106404_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104670","article-title":"Synthesis, in-vitro evaluation, molecular docking, and kinetic studies of pyridazine-triazole hybrid system as novel \u03b1-glucosidase inhibitors","volume":"109","author":"Moghimi","year":"2021","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bioorg.2023.106404_b0215","doi-asserted-by":"crossref","unstructured":"J.L. Felipe, T.B. Cassamale, L.D. Louren\u00e7o, D.B. Carvalho, A.R. das Neves, R.C. Duarte, et al. Anti-inflammatory, ulcerogenic and platelet activation evaluation of novel 1,4-diaryl-1,2,3-triazole neolignan-celecoxib hybrids. Bioorg Chem 119, 105485 (2022).","DOI":"10.1016\/j.bioorg.2021.105485"},{"key":"10.1016\/j.bioorg.2023.106404_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113162","article-title":"Design and synthesis of 7-O-1,2,3-triazole hesperetin derivatives to relieve inflammation of acute liver injury in mice","volume":"213","author":"Zheng","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bioorg.2023.106404_b0225","doi-asserted-by":"crossref","first-page":"708","DOI":"10.3390\/molecules26030708","article-title":"New 1, 2, 3-triazole-containing hybrids as antitumor candidates: Design, click reaction synthesis, DFT calculations, and molecular docking study","volume":"26","author":"El Azab","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2023.106404_b0230","doi-asserted-by":"crossref","first-page":"866","DOI":"10.3390\/ph14090866","article-title":"Synthesis and biological evaluation of 1, 2, 3-triazole tethered thymol-1, 3, 4-oxadiazole derivatives as anticancer and antimicrobial agents","volume":"14","author":"Almalki","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2023.106404_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113083","article-title":"Design, synthesis, and in vitro and in vivo anti-angiogenesis study of a novel vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitor based on 1, 2, 3-triazole scaffold","volume":"211","author":"Wang","year":"2021","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/j.bioorg.2023.106404_b0240","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bioorg.2017.07.007","article-title":"Design, synthesis and biological evaluation of some novel benzothiazole\/benzoxazole and\/or benzimidazole derivatives incorporating a pyrazole scaffold as antiproliferative agents","volume":"74","author":"Abdelgawad","year":"2017","journal-title":"Bioorganic chemistry"},{"key":"10.1016\/j.bioorg.2023.106404_b0245","article-title":"Design, synthesis, and biological evaluation of novel pyrido-dipyrimidines as dual topoisomerase II\/FLT3 inhibitors in leukemia cells","volume":"105752","author":"Abdelgawad","year":"2022","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bioorg.2023.106404_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115525","article-title":"Sulfonamide-based 4-anilinoquinoline derivatives as novel dual Aurora kinase (AURKA\/B) inhibitors: Synthesis, biological evaluation and in silico insights","volume":"28","author":"Al-Sanea","year":"2020","journal-title":"Bioorganic & medicinal chemistry"},{"key":"10.1016\/j.bioorg.2023.106404_b0255","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1080\/14756366.2021.1915302","article-title":"Development of 3-methyl\/3-(morpholinomethyl) benzofuran derivatives as novel antitumor agents towards non-small cell lung cancer cells","volume":"36","author":"Al-Sanea","year":"2021","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bioorg.2023.106404_b0260","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s00044-017-1798-9","article-title":"Design, synthesis and biological evaluation of new 4-(4-substituted-anilino) quinoline derivatives as anticancer agents","volume":"26","author":"Abdellatif","year":"2017","journal-title":"Med Chem Res"},{"key":"10.1016\/j.bioorg.2023.106404_b0265","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1007\/s11164-016-2851-x","article-title":"New benzothiazole\/benzoxazole-pyrazole hybrids with potential as COX inhibitors: Design, synthesis and anticancer activity evaluation","volume":"43","author":"Belal","year":"2017","journal-title":"Res Chem Intermed"},{"key":"10.1016\/j.bioorg.2023.106404_b0270","doi-asserted-by":"crossref","first-page":"10491","DOI":"10.3390\/ijms221910491","article-title":"Design, synthesis and anticancer profile of new 4-(1H-benzo[d]imidazol-1-yl)pyrimidin-2-amine-linked sulfonamide derivatives with V600EBRAF inhibitory effect","volume":"22","author":"Abdel-Maksoud","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bioorg.2023.106404_b0275","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3390\/molecules26020412","article-title":"A new CDK2 inhibitor with 3-hydrazonoindolin-2-one scaffold endowed with anti-breast cancer activity: Design, synthesis, biological evaluation, and in silico insights","volume":"26","author":"Al-Sanea","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2023.106404_b0280","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.bioorg.2016.03.011","article-title":"Design, synthesis and antitumor activity of novel pyrazolo [3, 4-d] pyrimidine derivatives as EGFR-TK inhibitors","volume":"66","author":"Abdelgawad","year":"2016","journal-title":"Bioorganic chemistry"},{"key":"10.1016\/j.bioorg.2023.106404_b0285","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.2174\/1385272822666181029111943","article-title":"Click synthesis, anticancer activity and molecular docking studies on pyridazinone scaffolds","volume":"22","author":"El Malah","year":"2018","journal-title":"Curr Org Chem"},{"key":"10.1016\/j.bioorg.2023.106404_b0290","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1039\/C1NR11434D","article-title":"Conformationally pre-organized and pH-responsive flat dendrons: Synthesis and self-assembly at the liquid\u2013solid interface","volume":"4","author":"El Malah","year":"2012","journal-title":"Nanoscale"},{"key":"10.1016\/j.bioorg.2023.106404_b0295","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1071\/CH17644","article-title":"Click synthesis of shape-persistent azodendrimers and their orthogonal self-assembly to nanofibres","volume":"71","author":"El Malah","year":"2018","journal-title":"Aust J Chem"},{"key":"10.1016\/j.bioorg.2023.106404_b0300","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/chem.201002491","article-title":"Designing structural motifs for clickamers: Exploiting the 1,2,3-triazole moiety to generate conformationally restricted molecular architectures","volume":"17","author":"Zornik","year":"2011","journal-title":"Chem Eur j"},{"key":"10.1016\/j.bioorg.2023.106404_b0305","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1080\/14756366.2020.1871335","article-title":"Click chemistry based synthesis, cytotoxic activity and molecular docking of novel triazole-thienopyrimidine hybrid glycosides targeting EGFR","volume":"36","author":"Khattab","year":"2021","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bioorg.2023.106404_b0310","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1002\/asia.201801805","article-title":"Synthesis and investigation of phthalazinones as antitubercular agents","volume":"14","author":"Santoso","year":"2019","journal-title":"Chem Asian J"},{"key":"10.1016\/j.bioorg.2023.106404_b0315","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.3390\/life11101070","article-title":"Identification of novel potential VEGFR-2 inhibitors using a combination of computational methods for drug discovery","volume":"11","author":"Al-Sanea","year":"2021","journal-title":"Life"},{"key":"10.1016\/j.bioorg.2023.106404_b0320","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ejmech.2019.04.015","article-title":"Discovery of dioxino[2,3-f]quinazoline derivative VEGFR-2 inhibitors exerting significant antipro-liferative activity in HUVECs and mice","volume":"175","author":"Fan","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bioorg.2023.106404_b0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104425","article-title":"Synthetic and medicinal chemistry of phthalazines: Recent developments, opportunities and challenges","volume":"105","author":"Zaib","year":"2020","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bioorg.2023.106404_b0330","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.bioorg.2023.106404_b0335","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0022-1759(86)90368-6","article-title":"Rapid colorimetric assay for cell growth and survival: Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability","volume":"89","author":"Denizot","year":"1986","journal-title":"J Immunol Methods"},{"issue":"10","key":"10.1016\/j.bioorg.2023.106404_b0340","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1158\/1535-7163.MCT-08-0013","article-title":"Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinases signaling","volume":"7","author":"Wihelm","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bioorg.2023.106404_b0345","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1083\/jcb.200403106","article-title":"Loss of Geminin induces rereplication in the presence of functional p53","volume":"165","author":"Melixetian","year":"2004","journal-title":"J Cell Biol"},{"key":"10.1016\/j.bioorg.2023.106404_b0350","unstructured":"http:\/\/www.molsoft.com\/."},{"key":"10.1016\/j.bioorg.2023.106404_b0355","unstructured":"http:\/\/www.molinspiration.com\/."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823000640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823000640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:44:30Z","timestamp":1758617070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206823000640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":71,"alternative-id":["S0045206823000640"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106404","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phthalazone tethered 1,2,3-triazole conjugates: In silico molecular docking studies, synthesis, in vitro antiproliferative, and kinase inhibitory activities","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106404","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106404"}}